{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T04:36:20Z","timestamp":1762144580248},"reference-count":47,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[1994,1,1]],"date-time":"1994-01-01T00:00:00Z","timestamp":757382400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,8,23]],"date-time":"2019-08-23T00:00:00Z","timestamp":1566518400000},"content-version":"vor","delay-in-days":9365,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Japanese Journal of Pharmacology"],"published-print":{"date-parts":[[1994]]},"DOI":"10.1254\/jjp.66.181","type":"journal-article","created":{"date-parts":[[2008,1,24]],"date-time":"2008-01-24T05:13:33Z","timestamp":1201151613000},"page":"181-189","source":"Crossref","is-referenced-by-count":47,"title":["Effects of Risperidone on Phencyclidine-Induced Behaviors: Comparison with Haloperidol and Ritanserin"],"prefix":"10.1016","volume":"66","author":[{"given":"Kiyoyuki","family":"Kitaichi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kiyofumi","family":"Yamada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takaaki","family":"Hasegawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroshi","family":"Furukawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshitaka","family":"Nabeshima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1254\/jjp.66.181_bib1","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1093\/schbul\/14.2.297","article-title":"The role of serotonin in schizophrenia","volume":"14","author":"Bleich","year":"1988","journal-title":"Schizophrenia Bull"},{"key":"10.1254\/jjp.66.181_bib2","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1007\/BF00428197","article-title":"Effect of serotonin antagonism in schizophrenia","volume":"85","author":"Ceulemans","year":"1985","journal-title":"Psychopharmacology (Berlin)"},{"key":"10.1254\/jjp.66.181_bib3","first-page":"364","article-title":"The risks and benefits of clozapine versus chlorpromazine","volume":"7","author":"Claghom","year":"1987","journal-title":"J Clin Psychopharmacol"},{"key":"10.1254\/jjp.66.181_bib4","first-page":"238","article-title":"Classification of typical and atypical antipsychotic drugs on the basis of dopamine D-l, D-2 and serotonin2 pKi values","volume":"251","author":"Meitzer","year":"1989","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1254\/jjp.66.181_bib5","first-page":"492","article-title":"Neuroleptic-induced extrapyramidal side-effects: clinical perspectives with ritanserin (R 55667), a new selective 5-HT2 receptor binding agent","volume":"40","author":"Bersani","year":"1986","journal-title":"Curr Ther Res"},{"key":"10.1254\/jjp.66.181_bib6","series-title":"Psychopharmacology: The Third Generation of Progress","first-page":"1573","article-title":"The behavioral pharmacology of phencyclidine.","author":"Balster","year":"1987"},{"key":"10.1254\/jjp.66.181_bib7","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1176\/ajp.148.10.1301","article-title":"Recent advances in the phencyclidine model of schizophrenia","volume":"148","author":"Javitt","year":"1991","journal-title":"Am J Psychiatry"},{"key":"10.1254\/jjp.66.181_bib8","first-page":"1139","article-title":"Potentiation in phencyclidine-induced serotonin-mediated behaviors after intracerebroventricular administration of 5,7-dihydroxytryptamine in rats","volume":"243","author":"Nabeshima","year":"1987","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1254\/jjp.66.181_bib9","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1093\/schbul\/17.2.263","article-title":"The mechanism of action of novel antipsychotic drugs","volume":"17","author":"Meitzer","year":"1991","journal-title":"Schizophrenia Bull"},{"key":"10.1254\/jjp.66.181_bib10","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/0014-2999(81)90086-8","article-title":"Acute and chronic phencyclidine effects on locomotor activity, stereotypy and ataxia in rats","volume":"73","author":"Castellani","year":"1981","journal-title":"Eur J Pharmacol"},{"key":"10.1254\/jjp.66.181_bib11","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/0160-5402(82)90040-7","article-title":"Development of dispositional tolerance to phencyclidine by osmotic minipump in the mouse","volume":"7","author":"Nabeshima","year":"1982","journal-title":"J Pharmacol Meth"},{"key":"10.1254\/jjp.66.181_bib12","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/0304-3940(83)90506-2","article-title":"Chronic phencyclidine increases methionine-enkepharlin level in mouse striatum","volume":"37","author":"Nabeshima","year":"1983","journal-title":"Neurosci Lett"},{"key":"10.1254\/jjp.66.181_bib13","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1016\/0091-3057(85)90075-9","article-title":"Phencyclidine-induced dopamine-dependent behaviors in chronic haloperidol-treated rats","volume":"23","author":"Yamaguchi","year":"1985","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1254\/jjp.66.181_bib14","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/S0091-3057(84)80102-1","article-title":"Serotonergic involvement in phencyclidine-induced behaviors","volume":"21","author":"Nabeshima","year":"1984","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1254\/jjp.66.181_bib15","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/0014-2999(87)90753-9","article-title":"Development of tolerance and supersensitivity to phencyclidine in rats after repeated administration of phencyclidine","volume":"135","author":"Nabeshima","year":"1987","journal-title":"Eur J Pharmacol"},{"key":"10.1254\/jjp.66.181_bib16","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1248\/yakushi1947.107.8_548","article-title":"Recent topics of phencyclidine, the drug induces psychosis","volume":"107","author":"Nabeshima","year":"1987","journal-title":"Yakugaku Zasshi"},{"key":"10.1254\/jjp.66.181_bib17","first-page":"661","article-title":"Biochemical profile of risperidone, a new antipsychotic","volume":"247","author":"Leysen","year":"1988","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1254\/jjp.66.181_bib18","first-page":"685","article-title":"Pharmacology of risperidone (R64 776), a new antipsychotic with serotonin-S2 and dopamine-D2 antagonistic properties","volume":"244","author":"Janssen","year":"1988","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1254\/jjp.66.181_bib19","series-title":"Novel Antipsychotic Drugs","first-page":"233","article-title":"Clinical overview of risperidone.","author":"Borison","year":"1992"},{"key":"10.1254\/jjp.66.181_bib20","first-page":"158","article-title":"Pharmacological profile of AD-4523, a novel antipsychotic with both potent dopamine-D2 and serotonin-S2 antagonists properties","volume":"264","author":"Oka","year":"1993","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1254\/jjp.66.181_bib21","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/0922-4106(93)90012-X","article-title":"Up-regulation of 5-HT2 receptors in the rat brain by repeated administration of SR 46349B, a selective 5-HT2 receptor antagonists","volume":"246","author":"Rinaldi-Carmona","year":"1993","journal-title":"Eur J Pharmacol"},{"key":"10.1254\/jjp.66.181_bib22","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/0304-3940(92)90738-S","article-title":"Denervation of dopaminergic neurons with 6-hydroxydopamine increases nerve growth factor content in rat brain","volume":"144","author":"Nitta","year":"1992","journal-title":"Neurosci Lett"},{"key":"10.1254\/jjp.66.181_bib23","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/0014-2999(78)90173-5","article-title":"The effect of phencyclidine on amphetamine stereotypy in rats","volume":"48","author":"Balster","year":"1978","journal-title":"Eur J Pharmacol"},{"key":"10.1254\/jjp.66.181_bib24","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/0091-3057(85)90137-6","article-title":"Acute and chronic behavioral between phencyclidine (PCP) and amphetamine: Evidence for a dopaminergic role in some PCP-induced behaviors","volume":"23","author":"Greenberg","year":"1985","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1254\/jjp.66.181_bib25","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/0014-2999(78)90293-5","article-title":"Phencyclidine-induced stereotyped behavior in monkeys: Antagonism by pimozide","volume":"52","author":"Schlemmer","year":"1978","journal-title":"Eur J Pharmacol"},{"key":"10.1254\/jjp.66.181_bib26","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/0014-2999(79)90279-6","article-title":"Behavioural rating scales for assessing phencyclidine-induced locomotor activity, stereotyped behavior and ataxia in rats","volume":"59","author":"Sturgeon","year":"1979","journal-title":"Eur J Pharmacol"},{"key":"10.1254\/jjp.66.181_bib27","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1248\/bpb1978.9.975","article-title":"Role of dopaminergic and GABAergic mechanisms in discrete brain areas in phencyclidine-induced behaviors locomotor stimulation and turning behavior","volume":"9","author":"Yamaguchi","year":"1986","journal-title":"J Pharmacobiodyn"},{"key":"10.1254\/jjp.66.181_bib28","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0006-8993(92)90530-M","article-title":"Increases in extracelluar dopamine levels and locomotor activity after direct infusion of phencyclidine into nucleus accumbens","volume":"577","author":"McCullough","year":"1992","journal-title":"Brain Res"},{"key":"10.1254\/jjp.66.181_bib29","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/0014-2999(83)90170-X","article-title":"Effect of lesions in the striatum, nucleus accumbens and medial raphe on phencyclidine-induced stereo-typed behaviors and hyperactivity in rats","volume":"91","author":"Nabeshima","year":"1983","journal-title":"Eur J Pharmacol"},{"key":"10.1254\/jjp.66.181_bib30","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/0014-2999(83)90142-5","article-title":"Phencyclidine-induced stereotyped behaviors in rats following specific neurotoxin lesions of the striatum","volume":"93","author":"Nabeshima","year":"1983","journal-title":"Eur J Pharmacol"},{"key":"10.1254\/jjp.66.181_bib31","first-page":"945","article-title":"Functional interaction between serotonin-S2 and dopamine-D2 neurotransmission as revealed by selective antagonism of hyper-reactivity to tryptamine and apomorphine","volume":"254","author":"Awouters","year":"1990","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1254\/jjp.66.181_bib32","first-page":"160","article-title":"Behavioral disinhibition and depression in amphetaminized rats: a comparison of risperidone, ocaperidone and haloperidol","volume":"260","author":"Megens","year":"1992","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1254\/jjp.66.181_bib33","first-page":"81","article-title":"Phencyclidine interacts with serotonin2 receptor, but not serotonin, receptor","volume":"5","author":"Nabeshima","year":"1984","journal-title":"Res Commun Subst Abuse"},{"key":"10.1254\/jjp.66.181_bib34","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/0014-2999(85)90550-3","article-title":"Acute and chronic phencyclidine changes serotonin receptors in rat brain","volume":"109","author":"Nabeshima","year":"1985","journal-title":"Eur J Pharmacol"},{"key":"10.1254\/jjp.66.181_bib35","first-page":"494","article-title":"In vitro and in vivo receptor binding and effects on monoamine turnover in rat brain regions of the novel antipsychotics risperidone and ocaperidone","volume":"41","author":"Leysen","year":"1992","journal-title":"Mol Pharmacol"},{"key":"10.1254\/jjp.66.181_bib36","first-page":"1162","article-title":"5-HT2 receptor blockade by ICI 169,369 and other 5-HT2 antagonists modulates the effects of D-2 dopamine receptor blockade","volume":"263","author":"Sailer","year":"1990","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1254\/jjp.66.181_bib37","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/0166-2236(88)90048-3","article-title":"Phencyclidine and psychotomimetic sigma opiates: Recent insights into their biochemical and physiological sites of action","volume":"11","author":"Sounders","year":"1988","journal-title":"Trends Neurosci"},{"key":"10.1254\/jjp.66.181_bib38","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/0014-2999(88)90527-4","article-title":"Novel antipsychotic drugs share high affinity for receptors","volume":"155","author":"Largent","year":"1988","journal-title":"Eur J Pharmacol"},{"key":"10.1254\/jjp.66.181_bib39","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/0006-3223(91)90209-5","article-title":"Selective loss of cerebral cortical sigma, but not PCP binding sites in schizophrenia","volume":"29","author":"Weissman","year":"1991","journal-title":"Biol Psychiatry"},{"key":"10.1254\/jjp.66.181_bib40","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/0006-8993(90)90709-K","article-title":"Sigma receptors modulate both A9 and A10 dopaminergic neurons in the rat brain: Functional interaction with NMDA receptors","volume":"524","author":"Iyenger","year":"1990","journal-title":"Brain Res"},{"key":"10.1254\/jjp.66.181_bib41","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/0028-3908(90)90173-O","article-title":"Increased release of dopamine in vivo by BMY-14802: Contrasting pattern to clozapine","volume":"29","author":"Rao","year":"1990","journal-title":"Neuropharmacology"},{"key":"10.1254\/jjp.66.181_bib42","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/0024-3205(93)90588-T","article-title":"NE-100, a novel sigma receptor ligand: in vivo tests","volume":"53","author":"Okuyama","year":"1993","journal-title":"Life Sci"},{"issue":"Suppl I","key":"10.1254\/jjp.66.181_bib43","doi-asserted-by":"crossref","first-page":"358P","DOI":"10.1016\/S0021-5198(19)51066-6","article-title":"Sigma ligands modulate \u039c\u039a-801-induced hyperlocomotion in rats","volume":"64","author":"Kitaichi","year":"1994","journal-title":"Jpn J Pharmacol"},{"key":"10.1254\/jjp.66.181_bib44","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1093\/schbul\/17.2.289","article-title":"New antipsychotics: classification, efficacy, and adverse effects","volume":"17","author":"Gerlach","year":"1991","journal-title":"Schizophrenia Bull"},{"key":"10.1254\/jjp.66.181_bib45","first-page":"31","article-title":"Combination therapy with haloperidol and orphenadrine in schizophrenia. A clinical and pharmacokinetic study","volume":"12","author":"Altamura","year":"1986","journal-title":"Encephale"},{"key":"10.1254\/jjp.66.181_bib46","first-page":"769","article-title":"Acute extrapyramidal syndrome in Cebus monkeys: Development mediated by dopamine D2 but not D1 receptors","volume":"249","author":"Coffin","year":"1989","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1254\/jjp.66.181_bib47","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/0014-2999(92)90525-9","article-title":"Effect of SCH 39166, a novel dopamine D1 receptor antagonist, on [3H]-acetylcholine release in rat striatal slices","volume":"211","author":"Tedford","year":"1992","journal-title":"Eur J Pharmacol"}],"container-title":["Japanese Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021519819356896?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021519819356896?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,9,2]],"date-time":"2021-09-02T14:27:13Z","timestamp":1630592833000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0021519819356896"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1994]]},"references-count":47,"journal-issue":{"issue":"2","published-print":{"date-parts":[[1994]]}},"alternative-id":["S0021519819356896"],"URL":"https:\/\/doi.org\/10.1254\/jjp.66.181","relation":{},"ISSN":["0021-5198"],"issn-type":[{"value":"0021-5198","type":"print"}],"subject":[],"published":{"date-parts":[[1994]]}}}